-
1
-
-
0033842405
-
Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria
-
Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria. Br J Dermatol 2000, 143:365-372.
-
(2000)
Br J Dermatol
, vol.143
, pp. 365-372
-
-
Grattan, C.E.1
O'Donnell, B.F.2
Francis, D.M.3
-
2
-
-
77955299623
-
Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema
-
Zuraw BL, Busse PJ, White M, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 2010, 363:513-522.
-
(2010)
N Engl J Med
, vol.363
, pp. 513-522
-
-
Zuraw, B.L.1
Busse, P.J.2
White, M.3
-
3
-
-
77955296289
-
Ecallantide for the treatment of acute attacks of hereditary angioedema
-
Cicardi M, Levy RJ, McNeil DL, et al. Ecallantide for the treatment of acute attacks of hereditary angioedema. N Engl J Med 2010, 363:523-531.
-
(2010)
N Engl J Med
, vol.363
, pp. 523-531
-
-
Cicardi, M.1
Levy, R.J.2
McNeil, D.L.3
-
4
-
-
43449123325
-
Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1
-
Contains references to many earlier double-blind, placebo-controlled studies of antihistamines as treatment for urticaria
-
Morgan M, Khan D Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 2008, 100:403-412. Contains references to many earlier double-blind, placebo-controlled studies of antihistamines as treatment for urticaria.
-
(2008)
Ann Allergy Asthma Immunol
, vol.100
, pp. 403-412
-
-
Morgan, M.1
Khan, D.2
-
5
-
-
45149086027
-
Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2
-
Contains references to immunomodulatory treatments for urticaria
-
Morgan M, Khan D Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2. Ann Allergy Asthma Immunol 2008, 100:517-526. Contains references to immunomodulatory treatments for urticaria.
-
(2008)
Ann Allergy Asthma Immunol
, vol.100
, pp. 517-526
-
-
Morgan, M.1
Khan, D.2
-
6
-
-
79251616362
-
Update on the acute treatment of hereditary angioedema
-
Review of the newly approved acute treatments and others currently being evaluated
-
Riedl MA Update on the acute treatment of hereditary angioedema. Allergy Asthma Proc 2011, 32:11-16. Review of the newly approved acute treatments and others currently being evaluated.
-
(2011)
Allergy Asthma Proc
, vol.32
, pp. 11-16
-
-
Riedl, M.A.1
-
7
-
-
78649947526
-
Angioedema: a review of 367 episodes presenting to three tertiary care hospitals
-
The mean age was 52 years, and about 50% of patients were taking an ACE inhibitor or angiotensin receptor blocker
-
Tai S, Mascaro M, Goldstein NA Angioedema: a review of 367 episodes presenting to three tertiary care hospitals. Ann Otol Rhinol Laryngol 2010, 119:836-841. The mean age was 52 years, and about 50% of patients were taking an ACE inhibitor or angiotensin receptor blocker.
-
(2010)
Ann Otol Rhinol Laryngol
, vol.119
, pp. 836-841
-
-
Tai, S.1
Mascaro, M.2
Goldstein, N.A.3
-
8
-
-
38349058150
-
Urticaria and angioedema
-
A concise approach to chronic urticaria geared toward the primary care physician
-
Amar S, Dreskin SC Urticaria and angioedema. Prim Care 2008, 35:141-157. A concise approach to chronic urticaria geared toward the primary care physician.
-
(2008)
Prim Care
, vol.35
, pp. 141-157
-
-
Amar, S.1
Dreskin, S.C.2
-
9
-
-
77958084414
-
Current treatment of hereditary angioedema: an update on clinical studies
-
Review focused on new treatments proven in randomized trials
-
Banerji A Current treatment of hereditary angioedema: an update on clinical studies. Allergy Asthma Proc 2010, 31:398-406. Review focused on new treatments proven in randomized trials.
-
(2010)
Allergy Asthma Proc
, vol.31
, pp. 398-406
-
-
Banerji, A.1
-
10
-
-
77955295556
-
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
-
2 receptor antagonist given as 30 mg subcutaneously, was better than tranexamic acid for treating acute attacks of hereditary angioedema
-
2 receptor antagonist given as 30 mg subcutaneously, was better than tranexamic acid for treating acute attacks of hereditary angioedema.
-
(2010)
N Engl J Med
, vol.363
, pp. 532-541
-
-
Cicardi, M.1
Banerji, A.2
Bracho, F.3
-
11
-
-
66149092706
-
Pathogenesis of chronic urticaria
-
A thorough discussion of the pathophysiology of chronic urticaria
-
Kaplan AP, Greaves M Pathogenesis of chronic urticaria. Clin Exp Allergy 2009, 39:777-787. A thorough discussion of the pathophysiology of chronic urticaria.
-
(2009)
Clin Exp Allergy
, vol.39
, pp. 777-787
-
-
Kaplan, A.P.1
Greaves, M.2
-
12
-
-
79251641987
-
Hereditary angioedema: historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis
-
Review including the role of C1-INH and bradykinin
-
Khan DA Hereditary angioedema: historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis. Allergy Asthma Proc 2011, 32:1-10. Review including the role of C1-INH and bradykinin.
-
(2011)
Allergy Asthma Proc
, vol.32
, pp. 1-10
-
-
Khan, D.A.1
-
13
-
-
50949089029
-
Hereditary angioedema
-
Comprehensive review of the pathophysiology and treatment of hereditary angioedema
-
Zuraw BL Hereditary angioedema. N Engl J Med 2008, 359:1027-1036. Comprehensive review of the pathophysiology and treatment of hereditary angioedema.
-
(2008)
N Engl J Med
, vol.359
, pp. 1027-1036
-
-
Zuraw, B.L.1
|